Evidence map›Paper›PMID 22480257›Full record

ArticleBMC genomics2012

VESPA: software to facilitate genomic annotation of prokaryotic organisms through integration of proteomic and transcriptomic data.

Elena S Peterson, Lee Ann McCue, Alexandra C Schrimpe-Rutledge, Jeffrey L Jensen, Hyunjoo Walker, Markus A Kobold, Samantha R Webb, Samuel H Payne, Charles Ansong, Joshua N Adkins and 2 more

Abstract read
In one paragraph

Article in BMC genomics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. The Molecular Toolset and Techniques Required to Build Cyanobacterial Cell Factories.Advances in biochemical engineering/biotechnology · 2023
    Article
  2. Review
  3. Article
  4. Review
  5. Methods, Tools and Current Perspectives in Proteogenomics.Molecular & cellular proteomics : MCP · 2017
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Reannotation of Yersinia pestis Strain 91001 Based on Omics Data.The American journal of tropical medicine and hygiene · 2016
    Article
  11. Article
  12. Article
  13. Next-generation annotation of prokaryotic genomes with EuGene-P: application to Sinorhizobium meliloti 2011.DNA research : an international journal for rapid publication of reports on genes and genomes · 2013
    Article
  14. Regulatory Tools for Controlling Gene Expression in Cyanobacteria.Advances in experimental medicine and biology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Elena S PetersonScientific Data Management, Pacific Northwest National Laboratory, Richland, WA, USA.
Lee Ann McCue
Alexandra C Schrimpe-Rutledge
Jeffrey L Jensen
Hyunjoo Walker
Markus A Kobold
Samantha R Webb
Samuel H Payne
Charles Ansong
Joshua N Adkins
William R Cannon
Bobbie-Jo M Webb-Robertson

Funding

Visual Analytics Software Environment for Proteomics Data IntegrationR01GM084892 · NIGMS · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI WEBB-ROBERTSON, BOBBIE-JO MARY · 2009 to 2010
$935k
NIGMS NIH HHS 1R01GM084892-01PHS HHS Y1-A1-8401
6 · The paper itself

Abstract

backgroundThe procedural aspects of genome sequencing and assembly have become relatively inexpensive, yet the full, accurate structural annotation of these genomes remains a challenge. Next-generation sequencing transcriptomics (RNA-Seq), global microarrays, and tandem mass spectrometry (MS/MS)-based proteomics have demonstrated immense value to genome curators as individual sources of information, however, integrating these data types to validate and improve structural annotation remains a major challenge. Current visual and statistical analytic tools are focused on a single data type, or existing software tools are retrofitted to analyze new data forms. We present Visual Exploration and Statistics to Promote Annotation (VESPA) is a new interactive visual analysis software tool focused on assisting scientists with the annotation of prokaryotic genomes though the integration of proteomics and transcriptomics data with current genome location coordinates.

resultsVESPA is a desktop Java™ application that integrates high-throughput proteomics data (peptide-centric) and transcriptomics (probe or RNA-Seq) data into a genomic context, all of which can be visualized at three levels of genomic resolution. Data is interrogated via searches linked to the genome visualizations to find regions with high likelihood of mis-annotation. Search results are linked to exports for further validation outside of VESPA or potential coding-regions can be analyzed concurrently with the software through interaction with BLAST. VESPA is demonstrated on two use cases (Yersinia pestis Pestoides F and Synechococcus sp. PCC 7002) to demonstrate the rapid manner in which mis-annotations can be found and explored in VESPA using either proteomics data alone, or in combination with transcriptomic data.

conclusionsVESPA is an interactive visual analytics tool that integrates high-throughput data into a genomic context to facilitate the discovery of structural mis-annotations in prokaryotic genomes. Data is evaluated via visual analysis across multiple levels of genomic resolution, linked searches and interaction with existing bioinformatics tools. We highlight the novel functionality of VESPA and core programming requirements for visualization of these large heterogeneous datasets for a client-side application. The software is freely available at https://www.biopilot.org/docs/Software/Vespa.php.

Indexed as

SoftwareBacteriaComputer GraphicsData MiningGene Expression ProfilingInternetMolecular Sequence AnnotationProteomicsSynechococcusYersinia pestis

Identifiers

PMID22480257
PMCPMC3364912

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.